| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 04/20/2011 | CN102018706A Postoperative anti-adhesion medicament |
| 04/19/2011 | CA2499006C Formulation which can be administered gastrointestinally, and the use thereof |
| 04/14/2011 | WO2011043739A1 Methods and compositions for maintenance of a functional wound |
| 04/14/2011 | US20110086801 Prevention and reduction of blood loss |
| 04/13/2011 | EP1840208B1 Method of inducing differentiation of skeletal muscle cell |
| 04/13/2011 | CN102008524A Application of volatile oil of foeniculum vulgare Mill. to preparation of medicament for preventing postoperative abdominal adhesion |
| 04/07/2011 | WO2011040888A1 A biodegradable composition or combination and uses thereof |
| 03/30/2011 | EP2301562A1 Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 03/30/2011 | CN101998868A Visible medical treatment material |
| 03/24/2011 | US20110071072 Antifungal Bone Cements |
| 03/23/2011 | EP2298355A2 Albumin fusion proteins |
| 03/23/2011 | EP2298278A1 Prevention and reduction of blood loss |
| 03/22/2011 | CA2471538C Pyrrolopyrimidines |
| 03/22/2011 | CA2412050C A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 03/16/2011 | EP2295541A1 Pluripotent stem cell derived from cardiac tissue |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2294428A1 A polymer adapted to release bioactive agents in vivo, pharmaceutical composition and method of preparation thereof |
| 03/15/2011 | US7906139 phosphatidylcholine, sphingomyelin, phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol, and cholesterol; for removal of extra-/intra- vascular fibrin clots/adhesions; for use during surgery; for treatment of otitis |
| 03/15/2011 | CA2461821C Polyfunctional biocompatible hydrogel and method for the production thereof |
| 03/10/2011 | WO2011027706A1 Porous structure |
| 03/10/2011 | US20110059177 Cardioplegia Solution for Cardiac Surgery |
| 03/10/2011 | US20110059176 Material for preventing tissue adhesion and material for preventing joint contracture |
| 03/10/2011 | US20110059061 Bioabsorbable Surgical Composition |
| 03/10/2011 | DE102009037514A1 Wasserlösliche Polysaccharidether und ihre Verwendung Water-soluble polysaccharide and their use |
| 03/09/2011 | EP2292622A1 New crystalline form of a triazolo(4,5-d)pyrimidine compound |
| 03/09/2011 | EP2291197A1 Use of histamine h4 antagonist for the treatment of post-operative adhesions |
| 03/03/2011 | US20110052712 Sprayable Polymers As Adhesion Barriers |
| 03/03/2011 | US20110052691 Sustained Release Systems and Preparation Method Thereof |
| 03/03/2011 | DE102009039665A1 Hydroxylapatitmaterial sowie Verfahren zu dessen Herstellung Hydroxylapatite and process for its preparation |
| 03/02/2011 | EP2289566A1 Medical device comprising a haemostatic agent and haemostatic kit comprising the medical device |
| 03/02/2011 | EP2289552A1 An immunosuppressive agent plus anti-TCR antibodies for the induction of chimerism in transplantation |
| 02/24/2011 | US20110044932 Crosslinked Polyalkyleneimine Hydrogels with Tunable Degradation Rates |
| 02/23/2011 | EP2286848A2 Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis |
| 02/22/2011 | CA2468133C Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 02/17/2011 | WO2010111137A3 Method for suppressing or preventing fibrous adhesion formation using a multicomponent aqueous oxychlorine composition prepared on-site |
| 02/15/2011 | US7888348 7-membered ring compound and method of production and pharmaceutical application thereof |
| 02/10/2011 | US20110034414 Fluoroalkyloxy alkanes, process for production and uses thereof |
| 02/10/2011 | US20110033517 Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same |
| 02/09/2011 | EP2281561A2 Use of LCK inhibitors for treatment of immunologic diseases |
| 02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 02/08/2011 | CA2259603C Use of polymeric compositions for reducing or eliminating post-surgical adhesion formation |
| 02/03/2011 | WO2011011881A1 Pharmaceutical compositions comprising modified fucans for use in the treatment of fibrous adhesions and other disorders |
| 02/03/2011 | CA2769147A1 Pharmaceutical compositions comprising modified fucans for use in the treatment of fibrous adhesions and other disorders |
| 02/02/2011 | EP2279738A1 The use of quaternary pyridinium salts as vasoprotective agents |
| 02/02/2011 | CN101961447A Novel preparation method, preparation and application of Chinese medicinal composition |
| 02/01/2011 | US7879878 Quinolone derivative or salt thereof |
| 02/01/2011 | US7879356 AB block polymers, comprising a polylactone part made from monomers such as lactic acid, and B is derived from hydroxyl, amine, or carboxyl terminated compound endcapped with nonreactive group; storage stablity; anti-adhesions |
| 01/27/2011 | US20110020475 Cardioplegic solution |
| 01/27/2011 | US20110020421 Biodegradable polyphosphazenes containing pyrrolidone side groups |
| 01/27/2011 | US20110020409 Silk Fibroin Hydrogels and Uses Thereof |
| 01/26/2011 | EP1365769B1 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
| 01/26/2011 | CN101959896A Crystalline phospholipid, method for its production and use in treating damaged tissue |
| 01/25/2011 | CA2410000C Compositions and methods comprising plasmid dna for wound healing and for repairing and regenerating tissue |
| 01/25/2011 | CA2385322C A substantially cell membrane impermeable compound and use thereof |
| 01/20/2011 | US20110015151 Combination of viscoelastics for use during surgery |
| 01/20/2011 | US20110014265 Implant Improving Local Bone Formation |
| 01/19/2011 | EP2275557A1 Albumin fusion proteins |
| 01/19/2011 | EP2274003A1 Composition and method for the inhibition of postoperative adhesions severity |
| 01/19/2011 | CN101160290B 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 01/13/2011 | US20110008460 Biomimetic hydroxyapatite composite materials and methods for the preparation thereof |
| 01/13/2011 | US20110008406 Silk Fibroin Hydrogels and Uses Thereof |
| 01/13/2011 | US20110008340 Anti-properdin antibodies |
| 01/13/2011 | US20110008316 Biological bioadhesive compositions and methods of preparation and use |
| 01/12/2011 | EP2271353A2 Oxygenation procedures for newborns and devices for use therein |
| 01/12/2011 | CN101366723B Medicinal composition |
| 01/11/2011 | US7867985 Injection of a synthetic synovial fluid containing one or more phosphatides, such as dipalmitoyl phosphatidylcholine, and a biodegradable dextran-glycidyl methacrylate copolymer hydrogel; phosphatides are incorporated into the cartilage of the arthritic, injured, or diseased joint; antiarthritic agents |
| 01/06/2011 | US20110003005 Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions |
| 01/05/2011 | EP2269665A1 Visible medical treatment material |
| 01/05/2011 | CN101935363A Method for producing pharmaceutical grade hyaluronic acid |
| 12/30/2010 | DE102009029717A1 Medical product, useful for post-surgical adhesion prophylaxis and/or hemostasis, comprises physically crosslinked polyvinyl alcohol and at least one biocompatible nucleating agent |
| 12/29/2010 | EP2267026A1 Albumin fusion proteins |
| 12/29/2010 | CN101028280B Lavage liquor preparation for operation and its production |
| 12/22/2010 | EP2262818A1 Crystalline phospholipid, method for its production and use in treating damaged tissue |
| 12/22/2010 | CN101264051B Modified release pharmaceutical formulation |
| 12/21/2010 | CA2408596C New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound |
| 12/16/2010 | US20100317745 Bioresorbable Polymers |
| 12/15/2010 | EP2260867A1 TWEAK receptor agonists as anti-angiogenic agents |
| 12/15/2010 | EP1905443B1 Liquid comprising trehalose for use in preventing tissue adhesion |
| 12/15/2010 | CN101918049A Monolithic in-situ cross-linked alginate implants |
| 12/15/2010 | CN101138635B Fibrin glue vasodilation agent sustained-release long-acting composition |
| 12/14/2010 | US7851442 and cerebral ischemia and or the onset of systemic inflammatory response particularly when associated with a surgical procedure(especially cardiothoracic surgery; kit comprising a dry lyophilized kallikrein inhibitor DX88 in a hermetically sealed container (rather than aprotinin) |
| 12/09/2010 | US20100310476 Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| 12/09/2010 | US20100310470 Immunomodulatory polymeric antigens for treating inflammatory pathologies |
| 12/09/2010 | CA2841499A1 Compositions and methods for preventing sternal wound infections |
| 12/08/2010 | EP2258363A1 Compositions for treatment of cancers |
| 12/08/2010 | CN101193645B Liquid for preventing tissue adhesion |
| 12/07/2010 | US7846468 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 12/02/2010 | WO2010136589A1 Treatment of tissue adhesion |
| 12/02/2010 | US20100303888 Composition for enhancing bone formation |
| 12/02/2010 | CA2761904A1 Treatment of tissue adhesion |
| 12/01/2010 | EP2254888A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 12/01/2010 | EP2254585A1 Chronic wound treatment |
| 12/01/2010 | EP1901786B1 Biomaterials in the form of fibres for use as medical devices in the treatment of wounds, and their production process |
| 12/01/2010 | EP1244790B1 Nucleic acids encoding polypeptides having chips activity |
| 11/25/2010 | US20100298254 Organ arrest, protection and preservation |
| 11/25/2010 | US20100297255 Malleable implants containing demineralized bone matrix |
| 11/24/2010 | EP2253703A1 Human coagulation factor VII variants |
| 11/24/2010 | EP2253321A1 Collyrium for the treatment of conial cornea with "cross-linking" trans-epithelial technique |
| 11/24/2010 | EP2252324A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 11/24/2010 | EP2252292A2 Cardioplegia solution for cardiac surgery |